Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
ROBERT I HADDAD
Listed Specialty: Medical Oncology
44 BINNEY ST, DANA FARBER CANCER INSTITUTE, BOSTON, MA, 02115
ROBERT HADDAD,
Yearly Payment Breakdown:
2018 Payments At a Glance
48
payments
$39,714
payment total
11
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
Category | Payments | Payment Value |
---|---|---|
Consulting |
10 | $33,404 |
Travel and Lodging |
18 | $4,648 |
Food and Beverage |
18 | $1,650 |
Education |
2 | $12 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
Product Name | Product Type | Payments† |
---|---|---|
Payments with no listed product |
N/A |
$17,933 |
TISLELIZUMAB |
drug |
$6,396 |
TECENTRIQ |
drug |
$6,080 |
NON-COVERED PRODUCT |
drug |
$3,209 |
OPDIVO |
drug |
$2,277 |
LENVIMA |
drug |
$1,916 |
IBRANCE |
drug |
$1,760 |
BAVENCIO |
drug |
$143 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in 2018
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
Jul 10, 2018 | $6,500 | No Listed Product | Consulting | MERCK SHARP & DOHME CORPORATION | |
Nov 15, 2018 | $6,000 | No Listed Product | Consulting | MERCK SHARP & DOHME CORPORATION | |
Apr 28, 2018 | $5,945 | TISLELIZUMAB | Consulting | CELGENE CORPORATION | |
Jan 11, 2018 | $4,430 | TECENTRIQ | Consulting | GENENTECH, INC. | |
Nov 9, 2018 | $2,500 | NON-COVERED PRODUCT | Consulting | GENENTECH USA, INC. | |
Jun 28, 2018 | $2,140 | No Listed Product | Consulting | ASTRAZENECA UK LIMITED | |
Sep 25, 2018 | $1,916 | LENVIMA | Consulting | EISAI CO., LTD. | |
Mar 19, 2018 | $1,760 | IBRANCE | Consulting | PFIZER INC. | |
Dec 28, 2018 | $1,725 | OPDIVO | Consulting | E.R. SQUIBB & SONS, L.L.C. | |
Nov 1, 2018 | $725 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
Jun 21, 2018 | $701 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
Oct 22, 2018 | $498 | OPDIVO | Travel and Lodging | E.R. SQUIBB & SONS, L.L.C. | |
Sep 30, 2018 | $488 | TECENTRIQ | Consulting | F. HOFFMANN-LA ROCHE AG | |
Jan 11, 2018 | $343 | TECENTRIQ | Travel and Lodging | GENENTECH, INC. | |
Nov 9, 2018 | $328 | NON-COVERED PRODUCT | Food and Beverage | GENENTECH USA, INC. | |
Apr 28, 2018 | $316 | No Listed Product | Travel and Lodging | CELGENE CORPORATION | |
Apr 28, 2018 | $297 | TISLELIZUMAB | Travel and Lodging | CELGENE CORPORATION | |
Nov 9, 2018 | $279 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH USA, INC. | |
Jan 11, 2018 | $274 | TECENTRIQ | Travel and Lodging | GENENTECH, INC. | |
Jun 21, 2018 | $230 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
Nov 1, 2018 | $170 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
Apr 28, 2018 | $154 | TISLELIZUMAB | Food and Beverage | CELGENE CORPORATION | |
Jul 10, 2018 | $150 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
Nov 15, 2018 | $150 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
Jun 21, 2018 | $150 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Feb 15, 2018 | $143 | BAVENCIO | Food and Beverage | PFIZER INC. | |
Jun 3, 2018 | $135 | No Listed Product | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
Jan 11, 2018 | $121 | TECENTRIQ | Travel and Lodging | GENENTECH, INC. | |
Jan 12, 2018 | $115 | TECENTRIQ | Food and Beverage | GENENTECH, INC. | |
Feb 15, 2018 | $105 | TECENTRIQ | Food and Beverage | ROCHE PRODUCTS LIMITED | |
Nov 9, 2018 | $103 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH USA, INC. | |
Nov 2, 2018 | $102 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
Jun 22, 2018 | $84 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
Nov 1, 2018 | $78 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Jan 11, 2018 | $70 | TECENTRIQ | Travel and Lodging | GENENTECH, INC. | |
Jun 22, 2018 | $65 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Jun 2, 2018 | $58 | TECENTRIQ | Food and Beverage | ROCHE PRODUCTS LIMITED | |
Jun 22, 2018 | $55 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Nov 2, 2018 | $50 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Nov 2, 2018 | $50 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Jun 22, 2018 | $46 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Oct 21, 2018 | $41 | TECENTRIQ | Food and Beverage | ROCHE PRODUCTS LIMITED | |
Jan 11, 2018 | $36 | TECENTRIQ | Food and Beverage | GENENTECH, INC. | |
Nov 2, 2018 | $35 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Mar 13, 2018 | $35 | OPDIVO | Travel and Lodging | E.R. SQUIBB & SONS, L.L.C. | |
Mar 13, 2018 | $7 | OPDIVO | Food and Beverage | E.R. SQUIBB & SONS, L.L.C. | |
Jun 1, 2018 | $6 | OPDIVO | Education | E.R. SQUIBB & SONS, L.L.C. | |
Oct 22, 2018 | $6 | OPDIVO | Education | E.R. SQUIBB & SONS, L.L.C. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.